#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Becker's muscular dystrophy Mantle cell lymphoma recurrent Congenital myopathy Chronic cutaneous lupus erythematosus Lupus nephritis Bladder cancer Interstitial lung disease Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Cholangiosarcoma Hypertriglyceridaemia Blastic plasmacytoid dendritic cell neoplasia Ischaemic stroke Stiff person syndrome Small cell lung cancer recurrent Intracranial germ cell tumour More trials…

Learn about Rare Diseases

Uterine leiomyosarcoma Chondrosarcoma – Treatment Cerebral arteriovenous malformation haemorrhagic – Treatment Usher’s syndrome – Basic Information Synovial sarcoma metastatic – Treatment Thrombotic thrombocytopenic purpura – Life with Disease Leiomyosarcoma recurrent – Basic Information Malignant fibrous histiocytoma – Diagnostics Chronic granulomatous disease – Diagnostics Chondrosarcoma metastatic – Basic Information More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Etripamil Warfarin Sodium MAGNESIUM CARBONATE HEAVY Risdiplam Disodium Folinate Tulisokibart Evg321 Ivabradine Hydrochloride Atropine Sulfate Monohydrate Lepidoglyphus Destructor Specific Nucleic Acid Sna-Xfsb SOVATELTIDE VANADIUM OXIDE SULFATE Quetiapine Mercaptamine Sodium Cromoglicate Ataluren Vixarelimab Escitalopram Oxalate Bleomycin Sulfate More therapies…

Learn about Your Condition

Bronchopulmonary aspergillosis Elderly Immune-mediated enterocolitis Cholangitis sclerosing BRAF gene mutation Burning mouth syndrome Upper limb fracture Tendon rupture Vasoplegia syndrome Antithrombin III deficiency Adenocarcinoma pancreas Wolfram syndrome Round cell liposarcoma Cardiac sarcoidosis Postprandial hypoglycaemia More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Behavioral Disciplines and Activities

Study on the Safety and Effectiveness of Guanfacine Hydrochloride and Atomoxetine Hydrochloride for Children and Adolescents with ADHD Aged 6 to 17 Years

Not recruiting

3 1 1
Investigated Diseases:
- Attention deficit hyperactivity disorder
Investigated Drugs:
- Atomoxetine Hydrochloride
- Guanfacine
Study on the Safety and Effectiveness of Olanzapine for Patients with Schizophrenia

Not recruiting

3 1 1 1
Investigated Diseases:
- Schizoaffective disorder
- Schizophrenia
Investigated Drugs:
- Olanzapine

1 … 3 4 5

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Behavioral Disciplines and Activities

Study on the Safety and Effectiveness of Guanfacine Hydrochloride and Atomoxetine Hydrochloride for Children and Adolescents with ADHD Aged 6 to 17 Years

Study on the Safety and Effectiveness of Olanzapine for Patients with Schizophrenia

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies